Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
3 Drug Classes That May Become Obsolete Within 3 Years
Motley Fool
Sun, 09/15/13 - 12:26 pm
interferon
hepatitis C
type 2 diabetes
dialysis
Is This Diabetes Drug Stock in Jeopardy?
Motley Fool
Sun, 09/15/13 - 12:25 pm
Novo Nordisk
Victoza
diabetes
type 2 diabetes
Lixisenatide NDA Withdrawn by Sanofi
Yahoo/Zacks
Sat, 09/14/13 - 10:52 am
lixisenatide
Sanofi
type 2 diabetes
diabetes
A Closer Look at 3 Players in Diabetes Treatments
Motley Fool
Sat, 08/17/13 - 10:55 am
type 2 diabetes
type 1 diabetes
Osiris Therapeutics
MannKind
diabetes
NovoNordisk
Positive Data on MannKind's Afrezza
Yahoo/Zacks
Sat, 08/17/13 - 10:38 am
MannKind
diabetes
Afrezza
type 2 diabetes
GlaxoSmithKline diabetes drug faces U.S. approval delay
Reuters
Sat, 08/3/13 - 10:11 am
albiglutide
type 2 diabetes
diabetes
Are These Diabetes Drugs Safe After All?
Motley Fool
Thu, 08/1/13 - 09:17 am
Januvia
Merck
Byetta
Bristol-Myers Squibb
diabetes
type 2 diabetes
Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks
The Street
Thu, 08/1/13 - 09:14 am
Lexicon Pharmaceuticals
LX4211
type 2 diabetes
diabetes
Why Biodel Will Have Positive Phase II Results
Seeking Alpha
Wed, 07/31/13 - 09:20 am
Biodel
BIOD-123
type 1 diabetes
type 2 diabetes
diabetes
First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes
Yahoo/PR Newswire
Wed, 07/31/13 - 09:11 am
Tradjenta
diabetes
type 2 diabetes
Boehringer Ingelheim
Eli Lilly
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Yahoo/Market Wired
Sun, 06/23/13 - 11:30 am
Sanofi
U300
insulin
type 2 diabetes
diabetes
Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:28 am
lixisenatide
type 2 diabetes
diabetes
Sanofi
Glaxo Diabetes Drug Shows Gastrointestinal Side Effects
Bloomberg
Sun, 06/23/13 - 11:22 am
GSK
albiglutide
diabetes
type 2 diabetes
Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:20 am
empagliflozin
type 2 diabetes
diabetes
Boehringer Ingelheim
Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting
Forbes
Fri, 05/24/13 - 11:08 am
Avandia
type 2 diabetes
diabetes
GSK
FDA
Steve Nissen
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments
Forbes
Fri, 05/24/13 - 11:09 am
Steve Nissen
GSK
Avandia
type 2 diabetes
diabetes
Strong Drug Performance Boosts Santarus Higher
Forbes
Fri, 05/24/13 - 10:48 am
Santarus
Cycloset
diabetes
type 2 diabetes
FDA reviewing heart risks of Glaxo diabetes pill
Yahoo/AP
Sat, 04/13/13 - 12:11 pm
GSK
Avandia
diabetes
type 2 diabetes
Repros Gets Additional Patents
Yahoo/Zacks
Sat, 04/13/13 - 11:25 am
type 2 diabetes
testosterone
Repros
Androxal
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Sat, 03/30/13 - 11:01 am
JNJ
diabetes
Invokana
type 2 diabetes
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »